Fasudil Hydrochloride and Ozagrel Sodium Combination Therapy for Patients with Aneurysmal Subarachnoid Hemorrhage: a Cross-Sectional Study Using a Nationwide Inpatient Database
JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES(2024)
摘要
Fasudil and ozagrel are drugs with the same indications for the treatment of cerebral vasospasm in Japan. However, there have been no definitive conclusions on the clinical efficacy of fasudil hydrochloride and ozagrel sodium monotherapy or their combination. Therefore, we aimed to investigate the effectiveness of the combined administration of fasudil hydrochloride and ozagrel sodium in Japanese patients with subarachnoid hemorrhage (SAH). This cross-sectional study used Diagnosis Procedure Combination data to assess patients who were hospitalized with SAH and received fasudil hydrochloride or ozagrel sodium between April 2016 and March 2020 (n = 17,346). The participants were divided into three groups based on the treatment received: fasudil hydrochloride monotherapy (F group, n = 10,484), ozagrel sodium monotherapy (O group, n = 465), and fasudil hydrochloride and ozagrel sodium combination therapy (FO group, n = 6,397). The primary outcome was in-hospital mortality. Multivariable adjusted logistic regression analysis (significance level, 5
更多查看译文
关键词
Subarachnoid hemorrhage,Fasudil hydrochloride,Ozagrel sodium,Cross-sectional study,In-hospital mortality
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要